{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:57:31Z","timestamp":1773658651861,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1007\/s00345-004-0455-3","type":"journal-article","created":{"date-parts":[[2004,9,28]],"date-time":"2004-09-28T07:38:18Z","timestamp":1096357098000},"page":"251-256","source":"Crossref","is-referenced-by-count":40,"title":["Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial"],"prefix":"10.1007","volume":"22","author":[{"given":"Y.","family":"Homma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,9,29]]},"reference":[{"key":"CR1","unstructured":"Abrams P, Kelleher CJ, Kerr LA, Rogers RG (2000) Overactive bladder significantly affects quality of life. Am J Managed Care 6 [Suppl]:S580?590"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0895-4356(98)00082-1","volume":"51","author":"Bullinger","year":"1998","unstructured":"Bullinger M, Alonso J, Apolone G, Leplege A, Sullivan M, Wood-Dauphinee S, Gandek B, Wagner A, Aaronson N, Bech P, Fukuhara Kaasa S, Ware JEJr (1998) Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 51:913?923","journal-title":"J Clin Epidemiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1016370925601","volume":"11","author":"Coyne","year":"2002","unstructured":"Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, Kurth H, Abrams P (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11:563?574","journal-title":"Qual Life Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s001929970003","volume":"10","author":"Drutz","year":"1999","unstructured":"Drutz HP, Appell RA, Gleason D, Klimberg I, Radomski S (1999) Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct 10:283?289","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"CR5","first-page":"225","volume":"10","author":"Homma","year":"1999","unstructured":"Homma Y, Gotoh M, Ando T, Fukuhara S (1999) Development of Japanese version of QOL questionnaires for urinary incontinence. Jpn J Neurogenic Bladder 10:225?236","journal-title":"Jpn J Neurogenic Bladder"},{"key":"CR6","first-page":"247","volume":"13","author":"Homma","year":"2002","unstructured":"Homma Y, Ando T, Yoshida M, Takei M, Momokazu G, Ohkawa A, Kageyama S, Fukihara S (2002) Validation of Japanese version of QoL questionnaires for urinary incontinence. Jpn J Neurogenic Bladder 13:247?257","journal-title":"Jpn J Neurogenic Bladder"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1464-410X.2003.04468.x","volume":"92","author":"Homma","year":"2003","unstructured":"Homma Y, Paick JS, Lee JG, Kawabe K (2003) Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with overactive bladder: a randomized, placebo-controlled trial. BJU Int 92:741?748","journal-title":"BJU Int"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","volume":"104","author":"Kelleher","year":"1997","unstructured":"Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374?1379","journal-title":"Br J Obstet Gynaecol"},{"key":"CR9","unstructured":"Kelleher CJ, Kreder KJ, Pleil AM, Burgess SM, Reese PR (2002) Long-term health-related quality of life of patients receiving extended release tolterodine for overactive bladder. Am J Man Care 8 [Suppl]:S616-S630"},{"key":"CR10","unstructured":"Kelleher CJ, Reese PR, Pleil AM, Okano GJ (2002) Health-related quality of life of patients receiving extended release tolterodine for overactive bladder. Am J Man Care 8 [Suppl]:S608-S615"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1464-410x.1999.00004.x","volume":"83","author":"Kobelt","year":"1999","unstructured":"Kobelt G, Kirchberger I, Malone-Lee J (1999) Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int 83:583?590","journal-title":"BJU Int"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1442-2042.2002.00460.x","volume":"9","author":"Lee","year":"2002","unstructured":"Lee JG, Hong JY, Choo M-S, Kwon HY, Chung DY, Lee KS, Lee JY, Lee T (2002) Tolterodine: as effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder. Int J Urol 9:19?24","journal-title":"Int J Urol"},{"key":"CR13","first-page":"13","volume":"11","author":"Nilvebrant","year":"2000","unstructured":"Nilvebrant L (2000) The mechanism of action of tolterodine. Rev Contemp Pharmacother 11:13?27","journal-title":"Rev Contemp Pharmacother"},{"key":"CR14","first-page":"69","volume":"2","author":"Pleil","year":"2001","unstructured":"Pleil AM, Reese PR, Kelleher CJ, Okano GJ (2001) Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodine. Health Econ Prev Care 2:69?75","journal-title":"Health Econ Prev Care"},{"key":"CR15","unstructured":"Pleil AM, Reese PR, Slayton T, Okano GJ (2001) Minimally perceived difference of the King?s Health Questionnaire: a comparison of results from two studies. Drug Information Association Quality of Life Conference, Hilton Head, South Carloina, March 2001, Abstract"},{"key":"CR16","unstructured":"Reese PR, Pleil AM, Slayton T, Okano GJ (2003) Multinational study of the reliability and validity of the King?s Health Questionnaire in patients with overactive bladder. QoL Res (in press)"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J","volume":"16","author":"Sankoh","year":"1997","unstructured":"Sankoh AJ, Huque MF, Dubey SD (1997) Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 16:2529?2542","journal-title":"Stat Med"},{"key":"CR18","unstructured":"Stewart W, Herzog R, Wein A, Cundiff G, Norton P, Corey R, on behalf of the NOBEL Program Research Team (2001) Prevalence and impact of overactive bladder in the U.S.: results from the NOBLE program. 22nd Annual Meeting of the American Urogynecologic Society, Chicago, 25?27 October 2001, Abstract"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1464-410X.2002.02963.x","volume":"90","author":"Van","year":"2002","unstructured":"Van der Vaart CH, De Leeuw JRJ, Roovers JPWR, Heintz AP (2002) The effects of urinary incontinence and overactive bladder symptoms on quality of life in young women. BJU Int 90:544?549","journal-title":"BJU Int"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","volume":"57","author":"Van","year":"2001","unstructured":"Van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A, on behalf of the Tolterodine Study Group (2001) Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57:414?421","journal-title":"Urology"},{"key":"CR21","first-page":"56","volume":"44","author":"Wein","year":"1999","unstructured":"Wein AJ, Rovner ES (1999) The overactive bladder: an overview for primary care health providers. Int J Fertil Menopausal Stud 44:56?66","journal-title":"Int J Fertil Menopausal Stud"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-004-0455-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-004-0455-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-004-0455-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:35:32Z","timestamp":1559036132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-004-0455-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1007\/s00345-004-0455-3","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}